======= ENTPD2 ======= == Gene Information == * **Official Symbol**: ENTPD2 * **Official Name**: ectonucleoside triphosphate diphosphohydrolase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=954|954]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y5L3|Q9Y5L3]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ENTPD2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ENTPD2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602012|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is the type 2 enzyme of the ecto-nucleoside triphosphate diphosphohydrolase family (E-NTPDase). E-NTPDases are a family of ecto-nucleosidases that hydrolyze 5'-triphosphates. This ecto-ATPase is an integral membrane protein. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: In the nervous system, could hydrolyze ATP and other nucleotides to regulate purinergic neurotransmission. Hydrolyzes ADP only to a marginal extent. The order of activity with different substrates is ATP > GTP > CTP = ITP > UTP >> ADP = UDP. |GDA1 CD39| |purine nucleoside diphosphate catabolic process| |purine ribonucleoside diphosphate catabolic process| |nucleoside-diphosphatase activity| |ribonucleoside diphosphate catabolic process| |nucleoside-triphosphatase activity| |nucleoside diphosphate catabolic process| |nucleobase-containing small molecule catabolic process| |purine ribonucleoside diphosphate metabolic process| |purine nucleoside diphosphate metabolic process| |ribonucleoside diphosphate metabolic process| |nucleoside phosphate catabolic process| |nucleoside diphosphate metabolic process| |basement membrane| |nucleobase-containing small molecule biosynthetic process| |organophosphate catabolic process| |platelet activation| |blood coagulation| |coagulation| |hemostasis| |nucleobase-containing compound catabolic process| |heterocycle catabolic process| |cellular nitrogen compound catabolic process| |small molecule catabolic process| |aromatic compound catabolic process| |nucleoside phosphate metabolic process| |wound healing| |organic cyclic compound catabolic process| |regulation of body fluid levels| |nucleobase-containing small molecule metabolic process| |response to wounding| |small molecule biosynthetic process| |organophosphate metabolic process| |endoplasmic reticulum membrane| |cell activation| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |organic cyclic compound biosynthetic process| |G protein-coupled receptor signaling pathway| |ATP binding| |cellular nitrogen compound biosynthetic process| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp224|CB-839 10μM R05 exp224]]|-2.12| |[[:results:exp437|Ethanol 0.003 R08 exp437]]|-1.92| |[[:results:exp360|Genistein 15μM R07 exp360]]|-1.75| |[[:results:exp485|GSK626616 14μM R08 exp485]]|-1.75| |[[:results:exp390|Pifithrin-alpha 20μM R07 exp390]]|-1.75| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6811 * **Expression level (log2 read counts)**: -7.68 {{:chemogenomics:nalm6 dist.png?nolink |}}